Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Gallo

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials GroupCesare Gridelli, Ciro Gallo, Frances A Shepherd, et al.
The Lancet. Oncology|September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trialsMassimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer|February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialFrancesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Thescientificworldjournal|June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patientsSimona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Contemporary Clinical Trials|October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocolMaria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trialCesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Critical Reviews in Oncology/Hematology|December 28, 2007
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trialFrancesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, et al.
Endocrine|March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective studyMaria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized studySabino De Placido, Giovanni Scambia, Giovanni Di Vagno, et al.
The Pharmacogenomics Journal|December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials GroupCesare Gridelli, Ciro Gallo, Frances A Shepherd, et al.
The Lancet. Oncology|September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trialsMassimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer|February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialFrancesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Thescientificworldjournal|June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patientsSimona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Contemporary Clinical Trials|October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocolMaria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trialCesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Critical Reviews in Oncology/Hematology|December 28, 2007
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trialFrancesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, et al.
Endocrine|March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective studyMaria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized studySabino De Placido, Giovanni Scambia, Giovanni Di Vagno, et al.
The Pharmacogenomics Journal|December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Pageof 12